|
|||||||
|
|||||||
HEPATITIS B VACCINE The hepatitis B vaccine protects against infection with the hepatitis B virus. The vaccine is a synthetic vaccine. It is 90% effective in children but is less effective in those over 30. The vaccine is given at six weeks, three months and five months. Most people recover from hepatitis B but some people can become chronic carriers and the virus can stay in the liver and lead to liver damage and cancer. People with Hepatitis B can pass the virus on to others through blood or sexual intercourse. By preventing infection with Hep B, the vaccine can prevent liver cancer caused by Hepatitis B. Over 1 billion doses of Hepatitis B vaccine have been used since 1981 with an outstanding record of safety and efficacy. Hepatitis B is the first vaccine against a human cancer.
Page last modified: May 2008 |
|